Technical Analysis for PRAX - Praxis Precision Medicines, Inc.

Grade Last Price % Change Price Change
F 15.51 -1.90% -0.30
PRAX closed down 1.9 percent on Thursday, July 29, 2021, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical PRAX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -1.90%
Lower Bollinger Band Walk Weakness -1.90%
Lower Bollinger Band Touch Weakness -1.90%
Oversold Stochastic Weakness -1.90%
Older End-of-Day Signals for PRAX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 4 hours ago
Lower Bollinger Band Support about 4 hours ago
Possible Inside Day about 5 hours ago
Possible NR7 about 5 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Praxis Precision Medicines, Inc. Description

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement Purdue Neuroscience Company; and a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Nervous System Disorders Central Nervous System Disorders Epilepsy Precision Medicine Major Depressive Disorder Depression Depressive Disorder Oligonucleotide Huntington's Disease Neuron Spinal Muscular Atrophy Treatment Of Major Depressive Disorder Antisense RNA Essential Tremor Receptor Positive Ionis

Is PRAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 60.95
52 Week Low 15.37
Average Volume 340,536
200-Day Moving Average 0.00
50-Day Moving Average 19.07
20-Day Moving Average 17.79
10-Day Moving Average 16.78
Average True Range 1.22
ADX 22.91
+DI 14.47
-DI 25.15
Chandelier Exit (Long, 3 ATRs) 16.77
Chandelier Exit (Short, 3 ATRs) 19.02
Upper Bollinger Bands 20.46
Lower Bollinger Band 15.12
Percent B (%b) 0.07
BandWidth 30.02
MACD Line -1.14
MACD Signal Line -0.98
MACD Histogram -0.1655
Fundamentals Value
Market Cap 593.44 Million
Num Shares 38.3 Million
Price-to-Sales 0.00
Price-to-Book 95.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.59
Resistance 3 (R3) 16.69 16.44 16.41
Resistance 2 (R2) 16.44 16.16 16.39 16.35
Resistance 1 (R1) 15.97 15.99 15.85 15.87 16.29
Pivot Point 15.72 15.72 15.65 15.67 15.72
Support 1 (S1) 15.25 15.44 15.13 15.15 14.73
Support 2 (S2) 15.00 15.27 14.95 14.67
Support 3 (S3) 14.53 15.00 14.61
Support 4 (S4) 14.43